Skip to main content
SpringerLink
Log in

An evaluation of hydrocortisone dosing for neonatal refractory hypotension

  • Original Article
  • Published:
Journal of Perinatology Submit manuscript

Abstract

Objective:

The objective of the study was to compare blood pressure, vasoactive medication requirements and adverse outcomes after administration of high- versus low-dose hydrocortisone (HC) in preterm infants.

Study Design:

This is a retrospective analysis of 106 infants ⩽28 weeks gestational age with hypotension requiring vasoactive infusions and high-dose (4 mg kg−1 per day, n=50), low-dose (1 to 3 mg kg−1 per day, n=20) or no HC (n=36) from 2011 to 2015. Groups were compared by two-tailed t-test or χ2, and correlation estimated by multivariable logistic regression.

Results:

There were no differences in measured efficacy between the low- and high-dose groups. Infants with pre-treatment cortisol >15 mcg dl−1 who received HC therapy showed less improvement in vasoactive burden, increased hyperglycemia (P=0.015) and increased death independent of HC dose (odds ratio 26.3, 3.5 to 198.3, P=0.002).

Conclusion:

These results support using the lowest effective HC dose in preterm infants. In addition, HC therapy should likely be avoided in infants who are not cortisol deficient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Goldstein RF, Thompson RJ, Oehler JM, Brazy JE . Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics 1995; 95 (2): 238–243.

    CAS  PubMed  Google Scholar 

  2. Seri I, Tan R, Evans J . Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 2001; 107 (5): 1070–1074.

    Article  CAS  Google Scholar 

  3. Barrington KJ . The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001; 1: 1.

    Article  CAS  Google Scholar 

  4. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114 (6): 1649–1657.

    Article  Google Scholar 

  5. Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK, Smith PB et al. Medication use in the neonatal intensive care unit. Am J Perinatol 2014; 31 (9): 811–821.

    Article  Google Scholar 

  6. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (1): 1–7.

    Article  CAS  Google Scholar 

  7. Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163 (7): 1723–1729.

    Article  CAS  Google Scholar 

  8. Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (4): 529–534.

    Article  CAS  Google Scholar 

  9. Watterberg KL . Hydrocortisone dosing for hypotension in newborn infants: less is more. J Pediatr 2016; 174 (23-26): e21.

    Google Scholar 

  10. Fernandez E, Schrader R, Watterberg K . Prevalence of low cortisol values in term and near-term infants with vasopressor-resistant hypotension. J Perinatol 2005; 25 (2): 114–118.

    Article  CAS  Google Scholar 

  11. Bourchier D, Weston PJ . Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997; 76 (3): F174–F178.

    Article  CAS  Google Scholar 

  12. Noori S, Friedlich P, Wong P, Ebrahimi M, Siassi B, Seri I . Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates. Pediatrics 2006; 118 (4): 1456–1466.

    Article  Google Scholar 

  13. Efird MM, Heerens AT, Gordon PV, Bose CL, Young DA . A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatol 2005; 25 (2): 119–124.

    Article  CAS  Google Scholar 

  14. Ng PC, Lee CH, Bnur FL, Chan IH, Lee AW, Wong E et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics 2006; 117 (2): 367–375.

    Article  Google Scholar 

  15. Vezina HE, Ng CM, Vazquez DM, Barks JD, Bhatt-Mehta V . Population pharmacokinetics of unbound hydrocortisone in critically ill neonates and infants with vasopressor-resistant hypotension. Pediatr Crit Care Med 2014; 15 (6): 546–553.

    Article  Google Scholar 

  16. Ibrahim H, Sinha IP, Subhedar NV . Corticosteroids for treating hypotension in preterm infants. Cochrane Database Syst Rev 2011; DOI: 10.1002/14651858.CD003662.pub4.

  17. Benders MJ, Groenendaal F, van Bel F, Ha Vinh R, Dubois J, Lazeyras F et al. Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease. Pediatr Res 2009; 66 (5): 555–559.

    Article  CAS  Google Scholar 

  18. Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005; 116 (1): 1–7.

    Article  Google Scholar 

  19. Parikh NA, Kennedy KA, Lasky RE, Tyson JE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS ONE 2015; 10 (9): e0137051.

    Article  Google Scholar 

  20. Finer NN, Powers RJ, Ou CH, Durand D, Wirtschafter D, Gould JB et al. Prospective evaluation of postnatal steroid administration: a 1-year experience from the California Perinatal Quality Care Collaborative. Pediatrics 2006; 117 (3): 704–713.

    Article  Google Scholar 

  21. Watterberg KL, Shaffer ML, Mishefske MJ, Leach CL, Mammel MC, Couser RJ et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics 2007; 120 (1): 40–48.

    Article  Google Scholar 

  22. Aucott SW, Watterberg KL, Shaffer ML, Donohue PK, Group PS . Do cortisol concentrations predict short-term outcomes in extremely low birth weight infants? Pediatrics 2008; 122 (4): 775–781.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, University of Washington, Seattle, WA, USA

    E S Peeples

Authors
  1. E S Peeples
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E S Peeples.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peeples, E. An evaluation of hydrocortisone dosing for neonatal refractory hypotension. J Perinatol 37, 943–946 (2017). https://doi.org/10.1038/jp.2017.68

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2017.68

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation